Markus Enzelberger (Versant)
Versant woos MorphoSys' ex-CSO to its booming discovery engine, with big plans for new startups
As MorphoSys celebrated the FDA’s acceptance of its first-ever BLA — complete with a priority review that could lead to a quick OK for its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
